Prudential Financial
FULC icon

Prudential Financial’s Fulcrum Therapeutics FULC Stock Holding History

Prudential Financial’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,540
Closed -$100K – 2467
2025
Q2 		$100K Sell
14,540
-8,185
-36% -$43.8K ﹤0.01% 2286
2025
Q1 		$65.4K Buy
22,725
+50
+0.2% +$184 ﹤0.01% 2171
2024
Q4 		$107K Hold
22,675
– – ﹤0.01% 2144
2024
Q3 		$81K Buy
+22,675
New +$168K ﹤0.01% 2599
2022
Q1 		– Sell
-28,770
Closed -$509K – 2634
2021
Q4 		$509K Buy
+28,770
New +$570K ﹤0.01% 2199

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial's FULC Position: Q3 2025 in Review

Prudential Financial sold out of Fulcrum Therapeutics (FULC) in Q3 2025, closing a stake of 14,540 shares — an estimated $100K sold.

Prudential Financial first reported a position in FULC in Q4 2021 and held it in 5 quarters. The position peaked at $509K in Q4 2021. 129 funds tracked by Wall St. Rank hold FULC as of Q3 2025.

  • Prudential Financial reported no remaining Fulcrum Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 14,540 Fulcrum Therapeutics shares in Q3 2025, an estimated $100K.
  • Prudential Financial first reported a position in Fulcrum Therapeutics in Q4 2021 and held it in 5 quarters.
  • Prudential Financial's Fulcrum Therapeutics position peaked at $509K in Q4 2021.
  • 129 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.